Publication:
Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland

cris.virtualsource.author-orcid1b65be99-ede2-4b0e-8e6d-1c720e453513
datacite.rightsopen.access
dc.contributor.authorSamaras, Panagiotis
dc.contributor.authorBargetzi, Mario
dc.contributor.authorBetticher, Daniel C
dc.contributor.authorDuchosal, Michel A
dc.contributor.authorHeim, Dominik
dc.contributor.authorHess, Urs
dc.contributor.authorKetterer, Nicolas
dc.contributor.authorLerch, Erika
dc.contributor.authorMatthes, Thomas
dc.contributor.authorMey, Ulrich
dc.contributor.authorPabst, Thomas Niklaus
dc.contributor.authorTaverna, Christian
dc.contributor.authorZander, Thilo
dc.contributor.authorRenner, Christoph
dc.date.accessioned2024-10-24T16:40:15Z
dc.date.available2024-10-24T16:40:15Z
dc.date.issued2015
dc.description.abstractThe availability of drugs such as thalidomide, bortezomib and lenalidomide changed the landscape in myeloma treatment and has extended the median survival up to 10 years with a substantial improvement in quality of life. This development prompted a Swiss expert panel to re-evaluate the current status and formulate updated clinical recommendations for the diagnosis and treatment of plasma cell myeloma. These recommendations should help clinicians in their decision making to achieve the best outcome based on currently available data.
dc.description.sponsorshipUniversitätsklinik für Medizinische Onkologie
dc.identifier.doi10.7892/boris.77200
dc.identifier.pmid25999239
dc.identifier.publisherDOI10.4414/smw.2015.14100
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/138995
dc.language.isoen
dc.publisherEMH Schweizerischer Ärzteverlag
dc.relation.ispartofSwiss medical weekly
dc.relation.issn1424-7860
dc.relation.organizationClinic of Medical Oncology
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleCurrent status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.startPagew14100
oaire.citation.volume145
oairecerif.author.affiliationUniversitätsklinik für Medizinische Onkologie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.description.ispublishedpub
unibe.eprints.legacyId77200
unibe.journal.abbrevTitleSWISS MED WKLY
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
smw-2015-14100.pdf
Size:
852.26 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by-nc-nd/4.0
Content:
published

Collections